[1]
“Efficacy And Safety Of Sofosbuvir/ Daclatasvir VS Sofosbuvir/Velpatasvir In Chronic Hepatitis C Patients ”, mfm, vol. 35, no. 12, Dec. 2024, doi: 10.60110/medforum.351217.